Inhibition of ocular neovascularization by novel anti-angiogenic compound-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of ocular neovascularization by novel anti-angiogenic compound

Published:2021-12 Issue: Volume:213 Page:108861
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Gau David,Vignaud Lucile,Francoeur Paul,Koes David^ORCID,Guillonneau Xavier^ORCID,Roy Partha^ORCID

Funder

U.S. Department of Defense

National Heart Lung and Blood Institute

National Cancer Institute

National Institute of General Medical Sciences

National Cancer Center

National Institutes of Health

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference16 articles.

1. Recent developments in age-related macular degeneration: a review;Al-Zamil;Clin. Interv. Aging,2017

2. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells;Allen;J. Biol. Chem.,2020

3. Age-related macular degeneration therapy: a review;Ammar;Curr. Opin. Ophthalmol.,2020

4. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients;Brown;Am. J. Ophthalmol.,2007

5. Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis;Ding;J. Cell Sci.,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell and molecular targeted therapies for diabetic retinopathy;Frontiers in Endocrinology;2024-06-14

2. Hyaluronan‐Sphingosine Polymersomes for Treatment of Ocular Neovascularization: Synthesis and Evaluation;Macromolecular Bioscience;2024-02-13

3. Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration;Pharmaceutics;2023-10-05

4. Vascular endothelial profilin-1 drives a protumorigenic tumor microenvironment and tumor progression in renal cancer;Journal of Biological Chemistry;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3